ForeSight-HF scores two nursing-home heart-failure cases

Mount Sinai authors describe ForeSight-HF (GPT-5 mini on ProviderLoop) recommending diuresis for a warm/wet and de-escalation for a cold/dry nursing-home patient; both were managed independently.

AI system

System

ForeSight-HF (large-language-model clinical decision support on the ProviderLoop platform)

Model

GPT-5 mini.

Release

Exact release not established.

Application developer

ProviderLoop (New York) with Mount Sinai clinicians

Role

The model generated care recommendations for illustrative cases that the authors compared with actual treatment.

Configuration

The authors accessed GPT-5 mini in late 2025.

Inputs and outputs

Not assessed

Autonomy

Not assessed

Workflow

The researchers supplied unstructured nursing-home documentation to GPT-5 mini through ProviderLoop. Their proposed workflow includes physician review, but the two illustrated patients received care independently of the model. [1]

Human oversight

Not assessed

Relation to AI

The model generated illustrative recommendations for two selected cases. The authors expressly state that its outputs did not guide care. Case 2 describes differences between the recommendations and the treatment that clinicians actually provided. No prospective effect on treatment or health was tested. [1]

AI contribution

The authors used the model to generate recommendations for two selected patients and state that its outputs did not guide care. They did not test whether the recommendations improved treatment or health. [1]

Benefits

Outcome identifiers

Not assessed

Benefit

ForeSight-HF recommended more diuretic treatment for one patient and less treatment for another. Clinicians managed both patients without using those recommendations. [1]

Category

Improved Task Accuracy

Status

Not assessed

Beneficiary groups

People. Organizations. Society.

Beneficiaries

Not assessed

Reach

Not assessed

Distribution and access

Not assessed

Duration

Not assessed

Expected?

Yes

Costs and harms

Not assessed

Measurement

Studies

Not assessed

Study design

Not assessed

Measurement

Not assessed

Setting and sample

Not assessed

Measures

Not assessed

Comparison

Not assessed

Results

Not assessed

Additional value from AI

Not assessed

Limitations

Not assessed

Denominators

Not assessed

Materials for replication

Not assessed

Money

Kind of value

Not assessed

Amount

Not assessed

Currency and prices

Not assessed

Period and unit

Not assessed

Realization

Not assessed

Recipients and payers

Not assessed

Gross or net

Not assessed

Included costs

Not assessed

Comparison

Not assessed

Method

Not assessed

Return and payback

Not assessed

People and places

Participants

Developer: ProviderLoop (New York) with Mount Sinai clinicians. Operator: Skilled nursing facilities served through the ProviderLoop platform (location not stated).

Jurisdictions

Benefit: New York, New York, USA (authors).

Ownership and control

Not assessed

Dependencies

Not assessed

Cross-border connections

Not assessed

Geopolitical implications

Not assessed

Follow-up

Conditions for replication

Prospective studies would need to test whether clinicians use the recommendations and whether patients benefit. An evaluation outside the developer’s team would help establish whether the findings hold elsewhere. [1]

Replication attempts

Not assessed

Later findings

The two illustrative cases were managed independently of the system for four months, and the cited source reports no later deployment data, trial or follow-up.

Availability

Not assessed

Institutional decision

Not assessed

Grounds

Not assessed

Action and result

Not assessed

Success criterion

Not assessed

Evidence

Source numbers

AIBD-0273-source-0001–0002 [1]

Citations

Numbered references below. [1]

Language

Not assessed

Source relationships

Developer [1]

Original evidence

The authors report two illustrative patients and state that the AI did not guide their care. They provide no raw clinical records or model logs. The cited clinical guidelines supply background rather than independent evidence about these patients. [1]

Access and versions

The complete article is available in the publisher’s XML through Europe PMC, including its references and declarations. The article provides no supplementary dataset or appendix. [1]

Supported findings

Not assessed

Evidence strength

Not assessed

Missing evidence

Not assessed

Grades

Assessed benefits

People. Organizations. Society.

Depth

Not assessed

Reasons

People: Both patients were managed independently of the AI system; outcomes not attributable. Organizations: No measured organizational effect; prospective validation is called for by the authors. Society: No attributable event.

Observed or intended

Not assessed

Rubric

Not assessed

Assessor and date

Not assessed

Alternative assessments

Not assessed

Fill

The makers' claim

Entry details

Kind

Not assessed

Field

Health; post-acute cardiology. Heart-failure patients in skilled nursing facilities.

Purpose

Generate heart-failure risk scores and management recommendations from nursing-facility documentation

Dates

Source published: 3 June 2026. Updated: 24 October 2026. [1]

Stage

Not assessed

Version

SHA-256: eecc9714603d…

References

Other identifiers

Not assessed

Category mappings

Not assessed

Brief

Not assessed

Revisions

5 revisions. Latest: 24 October 2026. [1]

Sources

  1. Case report Developer

    Emma Glajchen et al., “AI-Driven Heart Failure Decision Support in Skilled Nursing Facilities,” JACC: Case Reports 31, no. 29 (2026): 108561, https://doi.org/10.1016/j.jaccas.2026.108561; online June 3, 2026, “Intended Use” and the two case descriptions.

    Both retained quotations come from one vendor-affiliated case report, not two studies or independent confirmations.